semaglutide phase 1 Three new 3 REIMAGINE studies provide some of the strongest evidence yet for CagriSema® (cagrilintide + semaglutide) in type 2 diabetes. 🔹 REIMAGINE Studied people with early type 2 diabetes GLP-1 Weight Loss Is Changing

But the drugs common side effects nausea, vomiting, diarrhea and constipation tended to be worse in individuals over 65, which could exacerbate other underlying health conditions

Knight MG, Anekwe C, Washington K, Akam EY, Wang E, Stanford FC

References Parasar P, Ozcan P, Terry KL

One of the worlds largest regulatory body for drugs and medical devices, the US Food and Drug Administration (US FDA) has not approved any injectable drug for skin whitening and skin lightening 10

The side effects listed reflect available literature and research but may not represent all potential reactions

However, accumulating evidence has identified additional GI complications, including cholelithiasis, cholecystitis, gastroparesis, and bowel obstruction, which may warrant caution in susceptible individuals